Aytu Bioscience (AYTU) delays annual meeting of stock holders
Aytu Bioscience Inc (AYTU) currently trades at $1.57 and has 6.55% today. announced today that it’s the annual meeting of stockholders originally scheduled to be held on March 31, 2020, at 10:00 a.m. MST will be delayed to a later date to be determined by its Board of Directors (the “Annual Meeting”). The Company hopes to have the Annual Meeting by April 25, 2020, so that the record date for determining shareholders entitled to vote will remain unchanged. The Annual Meeting is being delayed due to the public health impact of the coronavirus pandemic (COVID-19) and the “shelter in place” order from the Governor of the State of Colorado. This change has been made out of an abundance of caution and is intended to support the health and well-being of the Company’s stockholders, employees and the Colorado community.
Based on this information, investorsQ rates this stock 5 out of 10. We give it this rating because Aytu BioScience has great potential as it is a commercial-stage specialty pharmaceutical company focused on commercializing novel products that address significant patient needs. The company currently markets a portfolio of prescription products addressing large primary care and pediatric markets. The high forecast for Aytu Bioscience Inc is $5.00 and the low is $4.75. Notably, the company’s market cap is $90.18 million with a 52 week high of $2.99 and a 52 week low of $0.34.